US President Donald Trump’s administration stands accused of deploying bullying tactics to promote greater market access for American pharmaceutical companies by stifling the production and distribution of more affordable, and usually totally legal, generic versions of drugs. India, Malaysia, South Korea, China, Indonesia, Japan, Australia, United Arab Emirates, New Zealand, Saudi Arabia and Turkey are […]